Company Profiles

driven by the PitchBook Platform

Moderna

Description

Developer of a new class medicines intended to treat inherited genetic disorders, hemophilic and blood factors and oncology. The company's mRNA technology platform accelerates drug discovery and speeds early development for mRNA-based vaccines and therapies spanning several therapeutic areas, as well as produces human proteins and antibodies inside patient cells, enabling clinicians to address currently undruggable targets and offer an alternative to existing drug modalities for a wide range of diseases and conditions.

PRIVATE

Status

201-500

Employees

Series F

Latest Deal Type

$474M

Latest Deal Amount

$1.34B

Total Amount Raised

15

Investors

Description

Developer of a new class medicines intended to treat inherited genetic disorders, hemophilic and blood factors and oncology. The company's mRNA technology platform accelerates drug discovery and speeds early development for mRNA-based vaccines and therapies spanning several therapeutic areas, as well as produces human proteins and antibodies inside patient cells, enabling clinicians to address currently undruggable targets and offer an alternative to existing drug modalities for a wide range of diseases and conditions.

Website:

www.modernatx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

320 Bent Street Cambridge, MA 02141United States +1 (617) 714-6500
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Moderna's full profile, request a free trial.

Moderna Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Moderna Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Moderna Investors (15)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
AlexionCorporationMinority000 0000000 0000
AstraZenecaCorporationMinority000 0000000 0000
BARDAOther000 0000000 0000
Bill & Melinda Gates FoundationNot-For-Profit Venture CapitalMinority000 0000000 0000
Boston Medical InvestorsVenture CapitalMinority000 0000000 0000
Alexion Corporation
AstraZeneca Corporation
BARDA Other
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital
Boston Medical Investors Venture Capital

Moderna Executive Team (16)

NameTitleBoard
Seat
Contact
Info
Stephane BancelChief Executive Officer & Board Member
Stephen Hoge MDPresident
Lorence Kim MDChief Financial Officer
Laura SchneckSenior Manager, Corporate Strategy
Annie DrapeauChief Human Resources Officer
Stephane Bancel Chief Executive Officer & Board Member
Stephen Hoge MD President
Lorence Kim MD Chief Financial Officer
Laura Schneck Senior Manager, Corporate Strategy
Annie Drapeau Chief Human Resources Officer

Moderna Board Members (12)

NameRepresentingRoleSinceContact
Info
Elizabeth Nabel MDModernaBoard Member000 0000
Henri TermeerModernaBoard Member000 0000
Israel RuizSelfBoard Member000 0000
John Mendlein Ph.DSelfBoard Member000 0000
Lee Babiss Ph.DSelfBoard Member000 0000
Elizabeth Nabel MD Board Member Moderna
Henri Termeer Board Member Moderna
Israel Ruiz Board Member Self
John Mendlein Ph.D Board Member Self
Lee Babiss Ph.D Board Member Self
Request full access to PitchBook